AbClon Inc Cash Flow Conversion Efficiency

Latest as of June 2026: -0.114x

AbClon Inc cash flow conversion efficiency. Based on the latest financial reports, AbClon Inc (174900) has a cash flow conversion efficiency ratio of -0.114x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-6.05 Billion ≈ $-4.10 Million USD) by net assets (₩53.07 Billion ≈ $35.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of AbClon Inc (2015–2025)

Cash flow conversion efficiency of AbClon Inc from 2015 to 2025. This chart illustrates how AbClon Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 174900 share price today for real-time trading data and today's change.

AbClon Inc Cash Flow Conversion Ratio Explained

AbClon Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

AbClon Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of AbClon Inc ranked by their cash flow conversion efficiency. Also see AbClon Inc (174900) total market value for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Joyvio Agriculture Development Co Ltd SHE:300268	-0.016x
P.C.B Tec TA:PCBT	0.056x
Cabaletta Bio Inc NASDAQ:CABA	-0.197x
Suprema Inc KQ:236200	0.047x
Vimta Labs Limited NSE:VIMTALABS	0.164x
Silver Storm Mining Ltd. V:SVRS	-0.085x
Profit Cultural & Creative Group Co Ltd SHE:300640	-0.018x
Texas Ventures Acquisition III Corp NASDAQ:TVA	-0.001x

Annual Cash Flow Conversion Efficiency for AbClon Inc (2015–2025)

The table below shows the annual cash flow conversion efficiency of AbClon Inc from 2015 to 2025. Review AbClon Inc (174900) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩60.44 Billion ≈ $40.96 Million	₩-13.83 Billion ≈ $-9.37 Million	-0.229x	+53.26%
2024-12-31	₩29.41 Billion ≈ $19.93 Million	₩-14.39 Billion ≈ $-9.75 Million	-0.490x	-40.56%
2023-12-31	₩27.23 Billion ≈ $18.46 Million	₩-9.48 Billion ≈ $-6.43 Million	-0.348x	-70.15%
2022-12-31	₩36.60 Billion ≈ $24.81 Million	₩-7.49 Billion ≈ $-5.08 Million	-0.205x	+54.15%
2021-12-31	₩19.36 Billion ≈ $13.12 Million	₩-8.64 Billion ≈ $-5.86 Million	-0.446x	-131.82%
2020-12-31	₩29.33 Billion ≈ $19.88 Million	₩-5.65 Billion ≈ $-3.83 Million	-0.193x	-1414.49%
2019-12-31	₩35.38 Billion ≈ $23.98 Million	₩-449.88 Million ≈ $-304.88K	-0.013x	-106.40%
2018-12-31	₩18.70 Billion ≈ $12.67 Million	₩3.71 Billion ≈ $2.52 Million	0.199x	+409.96%
2017-12-31	₩17.39 Billion ≈ $11.79 Million	₩-1.11 Billion ≈ $-755.45K	-0.064x	-274.68%
2016-12-31	₩11.98 Billion ≈ $8.12 Million	₩-204.92 Million ≈ $-138.87K	-0.017x	+89.66%
2015-12-31	₩13.31 Billion ≈ $9.02 Million	₩-2.20 Billion ≈ $-1.49 Million	-0.165x	--

About AbClon Inc

KQ:174900 Korea Biotechnology

Market Cap

$240.63 Million

₩355.07 Billion KRW

Market Cap Rank

#15640 Global

#535 in Korea

Share Price

₩17820.00

Change (1 day)

+3.30%

52-Week Range

₩16820.00 - ₩89100.00

All Time High

₩90600.00